Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2013

Open Access 01-12-2013 | Research article

Complementary alternative medicine use among patients with type 2 diabetes mellitus in the primary care setting: a cross-sectional study in Malaysia

Authors: Siew Mooi Ching, Zainul Amiruddin Zakaria, Fuziah Paimin, Mehrdad Jalalian

Published in: BMC Complementary Medicine and Therapies | Issue 1/2013

Login to get access

Abstract

Background

Limited study on the use of complementary alternative medicine (CAM) among patients with diabetes mellitus (DM), particularly in primary -care settings. This study seeks to understand the prevalence, types, expenditures, attitudes, beliefs, and perceptions of CAM use among patients with DM visiting outpatient primary care clinics.

Methods

This is a descriptive, cross-sectional study of 240 diabetic patients. CAM is defined as a group of diverse medical and healthcare systems, practices, and products that are not generally considered part of conventional Western medicine. Data analysis was done using SPSS v. 19 and multiple logistic regressions were used to identify predictors of CAM use.

Results

The prevalence of CAM use was 62.5 percent. Female were 1.8 times more likely than male in using CAM. Malays (75%) were the most frequent users, followed Indians (18%) and Chinese (6%). Biological therapy (50.0%) were the most widely used, followed by manipulative-body based systems (9.2%), energy system (8.8%), alternative medicine systems (4.6%) and mind-body system (1.7%). In biological therapy, a total of 30.4 percent, 24.2 percent, 13.3 percent, and 7.9 percent of diabetic patients consumed bitter gourd (Momordica Charantia), followed by Misai Kucing (Orthosiphon Stamineus Benth), garlic (Allium Sativum), and Sabah snake grass (Clinacanthus Nutans Lindau) respectively. The mean of the expenditure on CAM usage was RM 52.8 ± 101.9 (US $16.9 ± 32.5) per month. According to multiple logistic regression analyses, being Muslim (OR 5.258, 95 percent CI 2.952-9.368) had significant positive association with CAM use.

Conclusions

The prevalence of CAM use was high among diabetics. Islam faith is predictor for CAM use among Type 2 DM patients. The most-common herbs used were bitter gourd (Momordica Charantia) and Misai Kucing (Orthosiphon Stamineus, Benth). Further studies on the anti-glycemic activity of the isolated compound may be needed in the future.
Literature
1.
2.
3.
Barnes PM, Powell-Griner E, McFann K, Nahin RL: Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004, 343: 1-19.PubMed
4.
Chang HY, Wallis M, Tiralongo E: Use of complementary and alternative medicine among people living with diabetes: literature review. J Adv Nurs. 2007, 58: 307-319. 10.1111/j.1365-2648.2007.04291.x.CrossRefPubMed
5.
Lee GBW, Charn TC, Chew ZH, Ng TP: Complementary and alternative medicine use in patients with chronic diseases in primary care is associated with perceived quality of care and cultural beliefs. Fam Pract. 2004, 21: 654-660. 10.1093/fampra/cmh613.CrossRefPubMed
6.
Bausell RB, Lee WL, Berman BM: Demographic and health-related correlates to visits to complementary and alternative medical providers. Med Care. 2001, 39: 190-196. 10.1097/00005650-200102000-00009.CrossRefPubMed
7.
Nahas R, Moher M: Complementary and alternative medicine for the treatment of type 2 diabetes. Can Fam Physician. 2009, 55: 591-596.PubMedPubMedCentral
8.
Modak M, Dixit P, Londhe J, Ghaskadbi S, Paul A, Devasagayam T: Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr. 2007, 40: 163-173. 10.3164/jcbn.40.163.CrossRefPubMedPubMedCentral
9.
Al-Saeedi M, Elzubier AG, Bahnassi AA, Al-Dawood KM: Patterns of belief and use of traditional remedies by diabetic patients in Mecca, Saudi Arabia. East Mediterr Health J. 2003, 9: 99-107.PubMed
10.
Astin JA: Why patients use alternative medicine: results of a national study. JAMA. 1998, 279: 1548-1553. 10.1001/jama.279.19.1548.CrossRefPubMed
11.
Jamal P, Barkat AA, Amid A: Distribution of phenolics in various Malaysian medicinal plants. J Appl Sci. 2010, 10: 2658-2662.CrossRef
12.
Ibrahim J: The scientific values of Malaysian herbal products. Jurnal Sains Kesihatan Malaysia. 2006, 4: 59-70.
13.
Grzywacz JG, Lang W, Suerken C, Quandt SA, Bell RA, Arcury TA: Age, race, and ethnicity in the use of complementary and alternative medicine for health self-management: evidence from the 2002 National Health Interview Survey. J Aging Health. 2005, 17: 547-572. 10.1177/0898264305279821.CrossRefPubMed
14.
McMahan S, Lutz R: Alternative therapy use among the young-old (Ages 65 to 74): an evaluation of the MIDUS database. J Appl Gerontol. 2004, 23: 91-103. 10.1177/0733464804265604.CrossRef
15.
Remli R, Chan SC: Use of complementary medicine amongst diabetic patients in a public primary care clinic in Ipoh. Med J Malaysia. 2003, 58: 688-693.PubMed
16.
Hasan SS, Loon WC, Ahmadi K, Ahmed SI, Bukhari NI: Reasons, perceived efficacy and factors associated with complementary and alternative medicine use among Malaysian patients with diabetes mellitus. Br J Diabetes Vasc Dis. 2011, 11: 92-98. 10.1177/1474651410398367.CrossRef
17.
Leese GP, Gill GV, Houghton GM: Prevalence of complementary medicine usage within a diabetes clinic. Practical Diabetes. 1997, 14: 207-208. 10.1002/pdi.1960140711.CrossRef
18.
Clifford RM, Davis TM, Batty KT, Davis W: Prevalence and predictors of complementary medicine usage in diabetes: fremantle diabetes study. J Pharm Pract Res. 2003, 33: 260-264.CrossRef
19.
Ceylan S, Azal O, Taşlipinar A, Türker T, Açikel CH, Gulec M: Complementary and alternative medicine use among Turkish diabetes patients. Complement Ther Med. 2009, 17: 78-83. 10.1016/j.ctim.2008.07.003.CrossRefPubMed
20.
Moolasarn S, Sripa S, Kuessirikiet V, Sutawee K, Huasary J, Chaisila C, Chechom N, Sankan S: Usage of and cost of complementary/alternative medicine in diabetic patients. J Med Assoc Thai. 2005, 88: 1630-1637.PubMed
21.
Chang HA, Wallis M, Tiralongo E: Use of complementary and alternative medicine among people with type 2 diabetes in Taiwan: a cross-sectional survey. Evid Based Complement Alternat Med. 2011, 2010: 1-8.
22.
Argáez-López N, Wacher NH, Kumate-Rodríguez J, Cruz M, Talavera J, Rivera-Arce E, Lozoya X, DIMSS study Group: The use of complementary and alternative medicine therapies in type 2 diabetic patients in Mexico. Diabetes Care. 2003, 26: 2470-2471. 10.2337/diacare.26.8.2470.CrossRefPubMed
23.
Lee MS, Lim HJ, Moon SR: Survey of the use of complementary and alternative medicine among Korean diabetes mellitus patients. Pharmacoepidemiol Drug Saf. 2004, 13: 167-171. 10.1002/pds.877.CrossRefPubMed
24.
Kumar D, Bajaj S, Mehrotra R: Knowledge, attitude and practice of complementary and alternative medicines for diabetes. Public Health. 2006, 120: 705-711. 10.1016/j.puhe.2006.04.010.CrossRefPubMed
25.
Bell RA, Suerken CK, Grzywacz JG, Lang W, Quandt SA, Arcury TA: Complementary and alternative medicine use among adults with diabetes in the United States. Altern Ther Health Med. 2006, 12: 16-22.PubMed
26.
27.
Institute for Public Health (IPH): National Health and Morbidity Survey 2011 (NHMS 2011). Non-Communicable Diseases. 2011, II: 188-
28.
Hasan SS, Ahmed SI, Bukhari NI, Loon WC: Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics. Complement Ther Clin Pract. 2009, 15: 152-157. 10.1016/j.ctcp.2009.02.003.CrossRefPubMed
29.
Dunning T: Complementary therapies and diabetes. Complement Ther Nurs Midwifery. 2003, 9: 74-80. 10.1016/S1353-6117(02)00143-9.CrossRefPubMed
30.
Vincent C, Furnham A: Why do patients turn to complementary medicine? An empirical study. Br J Clin Psychol. 1996, 35: 37-48. 10.1111/j.2044-8260.1996.tb01160.x.CrossRefPubMed
31.
32.
Muela SH, Mushi AK, Ribera JM: The paradox of the cost and affordability of traditional and government health services in Tanzania. Health Policy Plan. 2000, 15: 296-302. 10.1093/heapol/15.3.296.CrossRefPubMed
33.
Funnell MM, Anderson RM: Empowerment and self-management of diabetes. Clinical Diabetes. 2004, 22: 123-127. 10.2337/diaclin.22.3.123.CrossRef
34.
Engel LW, Straus SE: Development of therapeutics: opportunities within complementary and alternative medicine. Nat Rev Drug Discov. 2002, 1: 229-236. 10.1038/nrd750.CrossRefPubMed
35.
Dunning T, Chan SP, Hew FL, Pendek R, Mohd MA, Ward G: Transcultural therapy: a cautionary tale on the use of complementary therapies. Diabetes Primary Care. 2001, 3: 58-63.
36.
Chatzimarkakis J: Why patients should be more empowered: a European perspective on lessons learned in the management of diabetes. J Diabetes Sci Technol. 2010, 4: 1570-1573.CrossRefPubMedPubMedCentral
37.
Arcury TA, Bell RA, Snively BM, Smith SL, Skelly AH, Wetmore LK, Quandt SA: Complementary and alternative medicine use as health self-management: rural older adults with diabetes. J Gerontol B Psychol Sci Soc Sci. 2006, 61: S62-S70. 10.1093/geronb/61.2.S62.CrossRefPubMedPubMedCentral
38.
Dannemann K, Hecker W, Haberland H, Herbst A, Galler A, Schäfer T, Brähler E, Kiess W, Kapellen TM: Use of complementary and alternative medicine in children with type 1 diabetes mellitus – prevalence, patterns of use, and costs. Pediatr Diabetes. 2008, 9: 228-235. 10.1111/j.1399-5448.2008.00377.x.CrossRefPubMed
39.
Kaptchuk TJ, Eisenberg DM: The persuasive appeal of alternative medicine. Ann Intern Med. 1998, 129: 1061-1065. 10.7326/0003-4819-129-12-199812150-00011.CrossRefPubMed
40.
41.
Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS: Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care. 2003, 26: 1277-1294. 10.2337/diacare.26.4.1277.CrossRefPubMed
42.
Baldwa VS, Bhandari CM, Pangaria A, Goyal RK: Clinical trial in patients with diabetes mellitus of an insulin-like compound obtained from plant source. Ups J Med Sci. 1977, 82: 39-41. 10.3109/03009737709179057.CrossRefPubMed
43.
Basch E, Gabardi S, Ulbricht C: Bitter melon (Momordica charantia): a review of efficacy and safety. Am J Health Syst Pharm. 2003, 60: 356-359.PubMed
44.
Welihinda J, Karunanayake EH, Sheriff MHH, Jayasinghe KSA: Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. J Ethnopharmacol. 1986, 17: 277-282. 10.1016/0378-8741(86)90116-9.CrossRefPubMed
45.
Mohamed EA, Mohamed AJ, Asmawi MZ, Sadikun A, Ebrika OS, Yam MF: Antihyperglycemic effect of Orthosiphon stamineus benth leaves extract and its bioassay-guided fractions. Molecules. 2011, 16: 3787-3801. 10.3390/molecules16053787.CrossRefPubMed
46.
47.
Ballali S, Lanciai F: Functional food and diabetes: a natural way in diabetes prevention?. Int J Food Sci Nutr. 2012, 63: 51-61. 10.3109/09637486.2011.637487.CrossRefPubMed
48.
Ashraf R, Khan RA, Ashraf I: Garlic (Allium sativum) supplementation with standard antidiabetic agent provides better diabetic control in type 2 diabetes patients. Pak J Pharm Sci. 2011, 24: 565-570.PubMed
49.
Sievenpiper JL, Arnason JT, Vidgen E, Leiter LA, Vuksan V: A systematic quantitative analysis of the literature of the high variability in ginseng (Panax spp.). Diabetes Care. 2004, 27: 839-840. 10.2337/diacare.27.3.839.CrossRefPubMed
50.
Blum A, Loerz C, Martin H-J, Staab-Weijnitz CA, Maser E: Momordica charantia extract, a herbal remedy for type 2 diabetes, contains a specific 11β-hydroxysteroid dehydrogenase type 1 inhibitor. J Steroid Biochem Mol Biol. 2012, 128: 51-55. 10.1016/j.jsbmb.2011.09.003.CrossRefPubMed
51.
Dans AML, Villarruz MVC, Jimeno CA, Javelosa MAU, Chua J, Bautista R, Velez GG: The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies. J Clin Epidemiol. 2007, 60: 554-559. 10.1016/j.jclinepi.2006.07.009.CrossRefPubMed
52.
Ooi CP, Yassin Z, Hamid TA: Momordica charantia for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2012, 8: CD007845
53.
Sakdarat S, Shuyprom A, Ayudhya TDN, Waterman PG, Karagianis G: Chemical composition investigation of the Clinacanthus nutans Lindau leaves. Thai J Phytopharm. 2006, 13 (2): 13-24.
54.
Hutch RA: Health and Healing: Spiritual, Pharmaceutical and Mechanical Medicine. J Relig Health. 2011, 27: 1-11. 10.1007/s10943-011-9545-x.
55.
Micozzi MS: Fundamentals of Complementary and Integrative Medicine. 2005, Saunders: Elsevier, 3
56.
Lim MK, Sadarangani P, Chan HL, Heng JY: Complementary and alternative medicine use in multiracial Singapore. Complement Ther Med. 2005, 13: 16-24. 10.1016/j.ctim.2004.11.002.CrossRefPubMed
57.
Aziz Z, Tey NP: Herbal medicines: prevalence and predictors of use among Malaysian adults. Complement Ther Med. 2009, 17: 44-50. 10.1016/j.ctim.2008.04.008.CrossRefPubMed
58.
Egede LE, Ye X, Zheng D, Silverstein MD: The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care. 2002, 25: 324-329. 10.2337/diacare.25.2.324.CrossRefPubMed
59.
Merican I: Traditional/complementary medicine: the way ahead. Med J Malaysia. 2002, 57: 261-265.PubMed
Metadata
Title
Complementary alternative medicine use among patients with type 2 diabetes mellitus in the primary care setting: a cross-sectional study in Malaysia
Authors
Siew Mooi Ching
Zainul Amiruddin Zakaria
Fuziah Paimin
Mehrdad Jalalian
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2013
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-13-148

Other articles of this Issue 1/2013

BMC Complementary Medicine and Therapies 1/2013 Go to the issue

Research article

The effect of RHIZOMA COPTIDIS and COPTIS CHINENSIS aqueous extract on radiation-induced skin injury in a rat model

Research article

A Chinese herbal formula, Yi-Qi-Fu-Sheng, inhibits migration/invasion of colorectal cancer by down-regulating MMP-2/9 via inhibiting the activation of ERK/MAPK signaling pathways

Research article

Activation of amygdala opioid receptors by electroacupuncture of Feng-Chi (GB20) acupoints exacerbates focal epilepsy

Research article

Electroacupuncture upregulates ERK signaling pathways and promotes adult hippocampal neural progenitors proliferation in a rat model of depression

Research article

Antihyperglycemic and antihyperlipidemic activities of aqueous extract of Hericium erinaceus in experimental diabetic rats

Research article

Studies on tracheorelaxant and anti-inflammatory activities of rhizomes of Polygonatum verticillatum